These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2543167)
1. [Pathogenesis of herpes zoster]. Smirnov IuK; Shishov AS Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):3-7. PubMed ID: 2543167 [TBL] [Abstract][Full Text] [Related]
2. Clinical and pathogenetic aspects of varicella-zoster. Plotkin SA Postgrad Med J; 1985; 61 Suppl 4():7-14. PubMed ID: 3014481 [TBL] [Abstract][Full Text] [Related]
5. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Mattiuzzi GN; Cortes JE; Talpaz M; Reuben J; Rios MB; Shan J; Kontoyiannis D; Giles FJ; Raad I; Verstovsek S; Ferrajoli A; Kantarjian HM Clin Cancer Res; 2003 Mar; 9(3):976-80. PubMed ID: 12631595 [TBL] [Abstract][Full Text] [Related]
6. Live attenuated varicella vaccine use in immunocompromised children and adults. Gershon AA; Steinberg SP; Gelb L Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495 [TBL] [Abstract][Full Text] [Related]
7. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors. Dunić I; Djurković-Djaković O; Vesić S; Zerjav S; Jevtović D Int J STD AIDS; 2005 Jul; 16(7):475-8. PubMed ID: 16004625 [TBL] [Abstract][Full Text] [Related]
8. Humoral and cellular immunity to varicella-zoster virus: an overview. Arvin AM J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410 [No Abstract] [Full Text] [Related]
9. Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus. Whitley RJ Pediatr Infect Dis J; 1989 Sep; 8(9):584-5. PubMed ID: 2552389 [No Abstract] [Full Text] [Related]
10. Herpes zoster: complications pathogenesis and pathology. The specialist view. MacLeod C; Murphy A Aust Fam Physician; 1982 Mar; 11(3):173-7. PubMed ID: 6280661 [TBL] [Abstract][Full Text] [Related]
11. Immune evasion as a pathogenic mechanism of varicella zoster virus. Abendroth A; Arvin AM Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797 [TBL] [Abstract][Full Text] [Related]
13. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. Quinlivan ML; Gershon AA; Steinberg SP; Breuer J J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408 [TBL] [Abstract][Full Text] [Related]
14. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401 [TBL] [Abstract][Full Text] [Related]
15. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Arvin AM Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912 [TBL] [Abstract][Full Text] [Related]
16. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115 [TBL] [Abstract][Full Text] [Related]
18. Clinical overview of varicella vaccine: development and early studies. Takahashi M Pediatrics; 1986 Oct; 78(4 Pt 2):736-41. PubMed ID: 3020493 [TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. Mancuso R; Delbue S; Borghi E; Pagani E; Calvo MG; Caputo D; Granieri E; Ferrante P J Med Virol; 2007 Feb; 79(2):192-9. PubMed ID: 17177306 [TBL] [Abstract][Full Text] [Related]
20. Molecular studies of Varicella zoster virus. Quinlivan M; Breuer J Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]